Rheumatic Manifestations and Immunological Abnormalities in Patients with HCV

TITLE: Rheumatic manifestations and immunological abnormalities in patients with chronic hepatitis C. A study in the Middle East.

Hepatitis C virus infection and rheumatic disorders are both common in the Middle East and share many clinical and immunological manifestations, raising diagnostic problems. We compared the prevalence of extrahepatic clinical manifestations and immunological disorders in 40 patients with chronic hepatitis C and in 42 carefully matched healthy controls. Polyarthralgia or polyarthritis was the most common rheumatic manifestation (35%) in the cases, followed by cutaneous vasculitis (15%). Glomerulonephritis and xerophthalmia were uncommon, and none of the cases had systemic vasculitis. Immunological abnormalities included serum rheumatoid factor (47.5%), cryoglobulins (30%), and one or more antitissue antibodies (37.5%). The prevalences of polyarthralgia, cutaneous vasculitis, rheumatoid factor, cryoglobulinemia, and anti-tissue antibodies were significantly higher in the hepatitis C group than in the control group. Our data suggest that patients in the Middle East who present with features of rheumatic or autoimmune diseases should be screened for hepatitis C.

AUTHOR: al-Awadhi A, al-Jarallah K, Hasan F, Olusi S, al-Attiyah R, Sugathan TN, al-Salem I, Attiyah Y, Sedequi H,Ahmed AH, Department of Medicine, School of Medicine, Kuwait University, Kuwait.
SOURCE: Rev Rhum Engl Ed 1998 Jun;65(6):372-377

Advertisement
Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

Why Occult Hepatitis B Can Be Hazardous
New research shows that even if Hepatitis B is hidden, it can still cause serious harm.

Advancement Made on Thwarting Hep C Replication and Resistance
A prominent UCLA researcher pinpoints the protein that blocks Hepatitis C viral replication and could ultimately end the problem of medication resistance during Hepatitis C therapy.

Progress in Studying Hep C Powered by Stem Cells
Spearheaded by a research team spanning several respected U.S. universities, stem cells are showing promise in understanding some of the challenges presented by the Hepatitis C virus.

More Hep C articles ...